Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics
<p>Abstract</p> <p>Background</p> <p>Asthma is a chronic inflammatory airway disease influenced by genetic and environmental factors that affects ~300 million people worldwide, leading to ~250,000 deaths annually. Glucocorticoids (GCs) are well-known therapeutics that a...
Main Authors: | Diez Diego, Goto Susumu, Fahy John V, Erle David J, Woodruff Prescott G, Wheelock Åsa M, Wheelock Craig E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1755-8794/5/27 |
Similar Items
-
Characteristics of Late-onset Asthma in Elderly Asthmatic Patients
by: Hirotaka Yasuba, et al.
Published: (2005-01-01) -
The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01) -
Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01) -
Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01) -
Impact of glucocorticoid on neurogenesis
by: Haruki Odaka, et al.
Published: (2017-01-01)